Replies to post #6354 on International Stem Cell Corp. (ISCO)

[Doctor_Hari_Seldon]

I think a market cap of 200 million is actually low for what this will be worth if a platform for treating Parkinsons and TBI is seen to be forthcoming. Lets say that we double the fully diluted share count to 36.4 million.. That would be about $5.50 per share. If they can build more of their revenue producing activities, that also would help. If we go to extended phases and have notable results, this should easily be a 700 million share cap value. Lets say by then there are 50 million shares. That is a $14 per share. If things don't falter along the way, which I must assume they can, I think we shall at least see that within the next 1 to 2 years.
Just my ignorant humble opinion.
HS